Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP11B1 | P15538 | 2/20 | 0.70 |
| ▸ | CYP11B2 | P19099 | 2/20 | 0.70 |
| ▸ | IDO1 | P14902 | 8/20 | 0.58 |
| ▸ | ASIC3 | Q9UHC3 | 2/20 | 0.49 |
| ▸ | POLB | P06746 | 1/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.47 |
| ▸ | LTA4H | P09960 | 1/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.43 |
| ▸ | CYP2E1 | P05181 | 1/20 | 0.43 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26265591 | 0.89 | CYP11B1 (0.85) | CYP11B1CYP11B2IDO1ASIC3POLB | |
| SCHEMBL20054668 | 0.84 | CYP11B1 (0.77) | CYP11B1CYP11B2IDO1ASIC3POLB | |
| SCHEMBL26260218 | 0.83 | CYP11B1 (0.82) | CYP11B1CYP11B2IDO1ASIC3POLB | |
| SCHEMBL2369049 | 0.82 | CYP11B1 (1.00) | CYP11B1CYP11B2IDO1ASIC3POLB | |
| SCHEMBL205481 | 0.81 | IDO1 (0.64) | CYP11B1CYP11B2IDO1ASIC3POLB | |
| SCHEMBL12647442 | 0.79 | CYP11B1 (0.70) | CYP11B1CYP11B2IDO1ASIC3POLB | |
| SCHEMBL1502406 | 0.79 | IDO1 (0.64) | CYP11B1CYP11B2IDO1ASIC3POLB | |
| SCHEMBL12647870 | 0.76 | CYP11B1 (0.64) | CYP11B1CYP11B2IDO1ASIC3POLB | |
| SCHEMBL12647819 | 0.74 | CYP11B1 (0.62) | CYP11B1CYP11B2IDO1ASIC3POLB | |
| SCHEMBL19792175 | 0.74 | IDO1 (0.52) | CYP11B1CYP11B2IDO1ASIC3POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2499115-B1 | PROCESS FOR PREPARING HEPATITIS C VIRUS INHIBITORS | BRISTOL MYERS SQUIBB HOLDINGS IRELAND (CH) | 2016-07-27 | — | — | EP | disclosed |
| WO-2011059887-A1 | HEPATITIS C VIRUS INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2011-05-19 | — | — | WO | disclosed |
| WO-2011059850-A1 | HEPATITIS C VIRUS INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2011-05-19 | — | — | WO | disclosed |
| WO-2011054834-A1 | BENZIMIDAZOLE-IMIDAZOLE DERIVATIVES | TIBOTEC PHARMACEUTICALS (IE) | 2011-05-12 | — | — | WO | disclosed |